Our stories

UMass Chan Medical School and MITRE, operator of federally funded research and development centers, announced the establishment of the Health AI Assurance Laboratory, a collaborative initiative to advance health artificial intelligence in the public interest. The initiative is at the forefront of efforts in the United States, and the first in Massachusetts, to ensure AI technology in health care is safe and effective for everyone using it.

In a new Voices of UMass Chan podcast, Margret Chang, MD, discusses the opioid use disorder crisis and how providing treatment in a primary care setting can reduce the stigma attached to getting help.  

Transcript

In a letter published in the New England Journal of Medicine, UMass Chan researchers reported analyses from the National Institutes of Health RADx program showing a small percentage of people, largely women with autoimmune disorders, persistently test positive on rapid home antigen tests for COVID-19 despite concurrently testing negative on molecular PCR tests.  

In an article for The Conversation, Nate Hafer, PhD, and Apurv Soni, MD, PhD’21, answer common questions related to how COVID-19 antigen tests perform against new variants. Anuradha Rao, PhD, assistant professor of pediatrics at Emory University also contributed to the article.

Dean Flotte testified in support of policies that would encourage and accelerate gene therapy for rare diseases, in a Feb. 29 hearing before the House Committee on Energy and Commerce’s Subcommittee on Health.

Morningside Graduate School of Biomedical Sciences students Atinuke G. Oyinbo and Favour Akabogu discussed their research for the Black Excellence series.

The scientists will use a human cerebral organoid platform to evaluate the role of COVID in neurodegenerative diseases, such as Alzheimer’s, Parkinson’s and dementia.  

The award from the Josiah Macy Jr. Foundation will help fund a pilot program aimed at improving communication skills of fellows and residents around patient apology and disclosure.  

UMass Chan is one of the first sites to participate in the Lupus Landmark Study and enroll patients in Lupus Nexus, a nationwide collaborative research biorepository.  

The MISSION program combines three evidence-based practices in a multidisciplinary team approach to treating adults with substance use disorders and co-occurring mental illness.

Transcript